| abstract |
This invention generally relates to the derivatives of novel 3,6 disubstituted azabicyclo[3.1.0] hexanes. The compounds of this invention are muscarinic receptor antagonists which are useful, inter-aila for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. nThe invention also relates to processes for the preparation of the compounds of the invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through MUSCARINIC receptors. |